These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 564941)

  • 41. Common bone features in osteomalacia, secondary hyperparathyroidism, and renal osteodystrophy.
    Verlooy H; De Roo M; Mortelmans L; Dequeker J
    Clin Nucl Med; 1991 May; 16(5):372-4. PubMed ID: 2054996
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease.
    Fogelman I; Carr D
    Clin Radiol; 1980 May; 31(3):321-6. PubMed ID: 7428273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
    Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index.
    Fogelman I; Citrin DL; Turner JG; Hay ID; Bessent RG; Boyle IT
    Eur J Nucl Med; 1979 Aug; 4(4):287-9. PubMed ID: 499249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole body retention of Tc-99m phosphate in Paget's disease of bone.
    Hadjipavlou A; Lisbona R; Garbuz D; Abibtbol JJ
    Clin Nucl Med; 1991 Jun; 16(6):435-8. PubMed ID: 1868658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bone scintigraphy with 99Tcm polyphosphate in uremic osteodystrophy].
    Meneghello A; Bertoli M; Naso A; Casara D; Camposampiero A; Presacco D
    Radiol Med; 1980 Oct; 66(10):760-1. PubMed ID: 6452654
    [No Abstract]   [Full Text] [Related]  

  • 47. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
    Fogelman I; Bessent R
    J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of bone scanning in osteomalacia.
    Fogelman I; McKillop JH; Bessent RG; Boyle IT; Turner JG; Greig WR
    J Nucl Med; 1978 Mar; 19(3):245-8. PubMed ID: 632900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imaging of metabolic bone diseases.
    Haugeberg G
    Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1127-39. PubMed ID: 19041081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
    Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
    Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical spectrum and diagnostic pitfalls of multiple abnormal uptakes on bone scintigraphy.
    Tsubaki F; Kurata S; Nagata S; Fujimoto K; Abe T
    Jpn J Radiol; 2016 Dec; 34(12):771-778. PubMed ID: 27688157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical significance of direct measurement of bone mineral content. 125I photon absorption measurement in 1252 cases].
    Ringe JD
    Fortschr Med; 1983 Feb; 101(5):186-90. PubMed ID: 6832681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantifications and sensitivity in bone scanning in the detection of bone metastases.
    Ritsema GH
    Diagn Imaging; 1982; 51(2):99-106. PubMed ID: 7075441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole-body retention of 99mTc-MPD in Paget's disease.
    Vattimo A; Cantalupi D; Righi G; Martini G; Nuti R; Turchetti V
    J Nucl Med Allied Sci; 1981; 25(1-2):5-10. PubMed ID: 6454766
    [No Abstract]   [Full Text] [Related]  

  • 58. Bone turnover in postmenopausal osteoporosis. Determined by whole body retention and urinary excretion of 99m-technetium diphosphonate.
    Thomsen K
    Dan Med Bull; 1988 Oct; 35(5):468-79. PubMed ID: 3066591
    [No Abstract]   [Full Text] [Related]  

  • 59. [General radiology of osteopathies].
    Ellegast HH
    Radiologe; 1973 Apr; 13(4):147-54. PubMed ID: 4716898
    [No Abstract]   [Full Text] [Related]  

  • 60. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.